Review




Structured Review

Spatial Transcriptomics Inc visium ffpe technology ffpe tissue sections
Fig. 4 | NP137 treatment inhibits EMT in patients with EC. a, Diagram showing EMT score calculated with Mak’s signature20 from RNA-seq of biopsies before (C1D1) and following two cycles of NP137 (C3D1) treatment (n = 12). Boxplots represent mean (25th–75th), whiskers range from minimum to maximum values and paired samples are identified on single-value representation; *P = 0.0161 by two-sided t-test. b, Swimmer plots showing individual evolution of EMT score for each patient; ΔEMT is the EMT score at C3D1 minus that at C1D1; ΔEMT < 0 means evolution towards epithelial phenotype (green) and >0 towards mesenchymal (red). c, Percentage of EpCAM high-expressing cells in C1D1 versus C3D1 biopsy samples as identified by IHC; *P = 0.0313 by Wilcoxon two-sided test (n = 6 patients). Boxplots represent mean (25th–75th), whiskers range from minimum to maximum values and paired samples are identified on single-value representation. d, Representative IHC of EpCAM in tumours in C1D1 and C3D1 for patient nos. 01-030, 01-035 and 01-040. Scale bar, 50 µm. e, Representative images of pancytokeratin (PanKRT) and vimentin (VIM) expression (colocalization of pancytokeratin (green) and vimentin (red) in the merged picture, right) in primary endometrial adenocarcinoma from patient no. 01-040 before and after NP137 treatment. Scale bars, 50 μm. Quantifications were performed on the full slides and similar results were observed for patient nos. 01-030 and 01-034. f, Analysis of tumour cell compartment in patient nos. 01-034 and 01-039 by <t>Visium</t> spatial gene expression. Violin plot of EMT UCell normalized enrichment score (NES) from tumoural histologically selected Visium spot between cells of C1D1 and C3D1 biopsy. ***P < 0.01 by Mann–Whitney two-sided test.
Visium Ffpe Technology Ffpe Tissue Sections, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/sections+tissue/pm37532934-375-3-0
Average 86 stars, based on 1 article reviews
visium ffpe technology ffpe tissue sections - by Bioz Stars, 2026-11
86/100 stars

Images

1) Product Images from "Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer."

Article Title: Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.

Journal: Nature

doi: 10.1038/s41586-023-06367-z

Fig. 4 | NP137 treatment inhibits EMT in patients with EC. a, Diagram showing EMT score calculated with Mak’s signature20 from RNA-seq of biopsies before (C1D1) and following two cycles of NP137 (C3D1) treatment (n = 12). Boxplots represent mean (25th–75th), whiskers range from minimum to maximum values and paired samples are identified on single-value representation; *P = 0.0161 by two-sided t-test. b, Swimmer plots showing individual evolution of EMT score for each patient; ΔEMT is the EMT score at C3D1 minus that at C1D1; ΔEMT < 0 means evolution towards epithelial phenotype (green) and >0 towards mesenchymal (red). c, Percentage of EpCAM high-expressing cells in C1D1 versus C3D1 biopsy samples as identified by IHC; *P = 0.0313 by Wilcoxon two-sided test (n = 6 patients). Boxplots represent mean (25th–75th), whiskers range from minimum to maximum values and paired samples are identified on single-value representation. d, Representative IHC of EpCAM in tumours in C1D1 and C3D1 for patient nos. 01-030, 01-035 and 01-040. Scale bar, 50 µm. e, Representative images of pancytokeratin (PanKRT) and vimentin (VIM) expression (colocalization of pancytokeratin (green) and vimentin (red) in the merged picture, right) in primary endometrial adenocarcinoma from patient no. 01-040 before and after NP137 treatment. Scale bars, 50 μm. Quantifications were performed on the full slides and similar results were observed for patient nos. 01-030 and 01-034. f, Analysis of tumour cell compartment in patient nos. 01-034 and 01-039 by Visium spatial gene expression. Violin plot of EMT UCell normalized enrichment score (NES) from tumoural histologically selected Visium spot between cells of C1D1 and C3D1 biopsy. ***P < 0.01 by Mann–Whitney two-sided test.
Figure Legend Snippet: Fig. 4 | NP137 treatment inhibits EMT in patients with EC. a, Diagram showing EMT score calculated with Mak’s signature20 from RNA-seq of biopsies before (C1D1) and following two cycles of NP137 (C3D1) treatment (n = 12). Boxplots represent mean (25th–75th), whiskers range from minimum to maximum values and paired samples are identified on single-value representation; *P = 0.0161 by two-sided t-test. b, Swimmer plots showing individual evolution of EMT score for each patient; ΔEMT is the EMT score at C3D1 minus that at C1D1; ΔEMT < 0 means evolution towards epithelial phenotype (green) and >0 towards mesenchymal (red). c, Percentage of EpCAM high-expressing cells in C1D1 versus C3D1 biopsy samples as identified by IHC; *P = 0.0313 by Wilcoxon two-sided test (n = 6 patients). Boxplots represent mean (25th–75th), whiskers range from minimum to maximum values and paired samples are identified on single-value representation. d, Representative IHC of EpCAM in tumours in C1D1 and C3D1 for patient nos. 01-030, 01-035 and 01-040. Scale bar, 50 µm. e, Representative images of pancytokeratin (PanKRT) and vimentin (VIM) expression (colocalization of pancytokeratin (green) and vimentin (red) in the merged picture, right) in primary endometrial adenocarcinoma from patient no. 01-040 before and after NP137 treatment. Scale bars, 50 μm. Quantifications were performed on the full slides and similar results were observed for patient nos. 01-030 and 01-034. f, Analysis of tumour cell compartment in patient nos. 01-034 and 01-039 by Visium spatial gene expression. Violin plot of EMT UCell normalized enrichment score (NES) from tumoural histologically selected Visium spot between cells of C1D1 and C3D1 biopsy. ***P < 0.01 by Mann–Whitney two-sided test.

Techniques Used: RNA Sequencing, Expressing, Paraffin-embedded Immunohistochemistry, Gene Expression, MANN-WHITNEY

Related Articles

Spatial Transcriptomics:

Article Title: Multi-Scale Transcriptomics Redefining the Tumor Immune Microenvironment
Article Snippet: scRNA-seq , Analyzing Transcriptomic Features at the Single-Cell Level , (1) Reveals cellular heterogeneity and subpopulation structure; (2) Identifies rare cells and transient state cells; (3) Suitable for developmental trajectory and cell lineage tracing analysis; (4) Constructs intercellular communication networks. , (1) High cost and limited sequencing depth; (2) Sparse data, high noise levels, small sample size, and limited representativeness; (3) Difficulty in preserving spatial information and disruption of tissue structure.. .. Spatial transcriptomics , Transcriptome sequencing preserving spatial information of tissue sections. , (1) Reveals the spatial distribution characteristics of gene expression; (2) Preserves tissue morphology and structural information; (3) Identifies functional regions and intercellular spatial interactions; (4) Aids in understanding the spatial ecology of the tumor microenvironment. , (1) Limited resolution, with partial signal mixing; (2) Large data volume and complex analysis algorithms; (3) High cost and relatively low technological maturity; (4) Difficulty in direct matching with large clinical samples.. .. Bulk RNA-seq + scRNA-seq , CIBERSORT MuSiC SCDC EPIC , Reference-based deconvolution using scRNA-seq-derived cell-type signatures , Immune composition profiling; Prognostic modeling; Cohort stratification..

Article Title: Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Article Snippet: .. Spatial transcriptomics using Visium FFPE technology FFPE tissue sections were placed on Visium slides and prepared according to the 10x Genomics protocols. .. After H&E staining, imaging and de-crosslinking steps, tissue sections were incubated with human-specific probes targeting 17,943 genes (10x Genomics, Visium Human Transcriptome Probe Set v.1.0).

Sequencing:

Article Title: Multi-Scale Transcriptomics Redefining the Tumor Immune Microenvironment
Article Snippet: scRNA-seq , Analyzing Transcriptomic Features at the Single-Cell Level , (1) Reveals cellular heterogeneity and subpopulation structure; (2) Identifies rare cells and transient state cells; (3) Suitable for developmental trajectory and cell lineage tracing analysis; (4) Constructs intercellular communication networks. , (1) High cost and limited sequencing depth; (2) Sparse data, high noise levels, small sample size, and limited representativeness; (3) Difficulty in preserving spatial information and disruption of tissue structure.. .. Spatial transcriptomics , Transcriptome sequencing preserving spatial information of tissue sections. , (1) Reveals the spatial distribution characteristics of gene expression; (2) Preserves tissue morphology and structural information; (3) Identifies functional regions and intercellular spatial interactions; (4) Aids in understanding the spatial ecology of the tumor microenvironment. , (1) Limited resolution, with partial signal mixing; (2) Large data volume and complex analysis algorithms; (3) High cost and relatively low technological maturity; (4) Difficulty in direct matching with large clinical samples.. .. Bulk RNA-seq + scRNA-seq , CIBERSORT MuSiC SCDC EPIC , Reference-based deconvolution using scRNA-seq-derived cell-type signatures , Immune composition profiling; Prognostic modeling; Cohort stratification..

Preserving:

Article Title: Multi-Scale Transcriptomics Redefining the Tumor Immune Microenvironment
Article Snippet: scRNA-seq , Analyzing Transcriptomic Features at the Single-Cell Level , (1) Reveals cellular heterogeneity and subpopulation structure; (2) Identifies rare cells and transient state cells; (3) Suitable for developmental trajectory and cell lineage tracing analysis; (4) Constructs intercellular communication networks. , (1) High cost and limited sequencing depth; (2) Sparse data, high noise levels, small sample size, and limited representativeness; (3) Difficulty in preserving spatial information and disruption of tissue structure.. .. Spatial transcriptomics , Transcriptome sequencing preserving spatial information of tissue sections. , (1) Reveals the spatial distribution characteristics of gene expression; (2) Preserves tissue morphology and structural information; (3) Identifies functional regions and intercellular spatial interactions; (4) Aids in understanding the spatial ecology of the tumor microenvironment. , (1) Limited resolution, with partial signal mixing; (2) Large data volume and complex analysis algorithms; (3) High cost and relatively low technological maturity; (4) Difficulty in direct matching with large clinical samples.. .. Bulk RNA-seq + scRNA-seq , CIBERSORT MuSiC SCDC EPIC , Reference-based deconvolution using scRNA-seq-derived cell-type signatures , Immune composition profiling; Prognostic modeling; Cohort stratification..

Gene Expression:

Article Title: Multi-Scale Transcriptomics Redefining the Tumor Immune Microenvironment
Article Snippet: scRNA-seq , Analyzing Transcriptomic Features at the Single-Cell Level , (1) Reveals cellular heterogeneity and subpopulation structure; (2) Identifies rare cells and transient state cells; (3) Suitable for developmental trajectory and cell lineage tracing analysis; (4) Constructs intercellular communication networks. , (1) High cost and limited sequencing depth; (2) Sparse data, high noise levels, small sample size, and limited representativeness; (3) Difficulty in preserving spatial information and disruption of tissue structure.. .. Spatial transcriptomics , Transcriptome sequencing preserving spatial information of tissue sections. , (1) Reveals the spatial distribution characteristics of gene expression; (2) Preserves tissue morphology and structural information; (3) Identifies functional regions and intercellular spatial interactions; (4) Aids in understanding the spatial ecology of the tumor microenvironment. , (1) Limited resolution, with partial signal mixing; (2) Large data volume and complex analysis algorithms; (3) High cost and relatively low technological maturity; (4) Difficulty in direct matching with large clinical samples.. .. Bulk RNA-seq + scRNA-seq , CIBERSORT MuSiC SCDC EPIC , Reference-based deconvolution using scRNA-seq-derived cell-type signatures , Immune composition profiling; Prognostic modeling; Cohort stratification..

Functional Assay:

Article Title: Multi-Scale Transcriptomics Redefining the Tumor Immune Microenvironment
Article Snippet: scRNA-seq , Analyzing Transcriptomic Features at the Single-Cell Level , (1) Reveals cellular heterogeneity and subpopulation structure; (2) Identifies rare cells and transient state cells; (3) Suitable for developmental trajectory and cell lineage tracing analysis; (4) Constructs intercellular communication networks. , (1) High cost and limited sequencing depth; (2) Sparse data, high noise levels, small sample size, and limited representativeness; (3) Difficulty in preserving spatial information and disruption of tissue structure.. .. Spatial transcriptomics , Transcriptome sequencing preserving spatial information of tissue sections. , (1) Reveals the spatial distribution characteristics of gene expression; (2) Preserves tissue morphology and structural information; (3) Identifies functional regions and intercellular spatial interactions; (4) Aids in understanding the spatial ecology of the tumor microenvironment. , (1) Limited resolution, with partial signal mixing; (2) Large data volume and complex analysis algorithms; (3) High cost and relatively low technological maturity; (4) Difficulty in direct matching with large clinical samples.. .. Bulk RNA-seq + scRNA-seq , CIBERSORT MuSiC SCDC EPIC , Reference-based deconvolution using scRNA-seq-derived cell-type signatures , Immune composition profiling; Prognostic modeling; Cohort stratification..

Imaging:

Article Title: Single-Cell Omics in Legumes: Research Trends and Applications.
Article Snippet: .. Spatial transcriptomics can be categorized into (1) RNA capture-based approaches (e.g., 10× Visium, Slide-seq) where tissue sections are placed on slides patterned with spatially barcoded primers that capture RNA molecules and tag them to record their spatial locations; (2) in probe- or imaging-based approaches [e.g., multiplexed error-robust fluorescence in situ hybridization (MERFISH), sequential FISH (seqFISH), Xenium in situ], where fluorescently labeled probes hybridize target transcripts on a tissue cross-section, enabling direct visualization of transcripts locations at high spatial resolution [71]. ..

Fluorescence:

Article Title: Single-Cell Omics in Legumes: Research Trends and Applications.
Article Snippet: .. Spatial transcriptomics can be categorized into (1) RNA capture-based approaches (e.g., 10× Visium, Slide-seq) where tissue sections are placed on slides patterned with spatially barcoded primers that capture RNA molecules and tag them to record their spatial locations; (2) in probe- or imaging-based approaches [e.g., multiplexed error-robust fluorescence in situ hybridization (MERFISH), sequential FISH (seqFISH), Xenium in situ], where fluorescently labeled probes hybridize target transcripts on a tissue cross-section, enabling direct visualization of transcripts locations at high spatial resolution [71]. ..

In Situ Hybridization:

Article Title: Single-Cell Omics in Legumes: Research Trends and Applications.
Article Snippet: .. Spatial transcriptomics can be categorized into (1) RNA capture-based approaches (e.g., 10× Visium, Slide-seq) where tissue sections are placed on slides patterned with spatially barcoded primers that capture RNA molecules and tag them to record their spatial locations; (2) in probe- or imaging-based approaches [e.g., multiplexed error-robust fluorescence in situ hybridization (MERFISH), sequential FISH (seqFISH), Xenium in situ], where fluorescently labeled probes hybridize target transcripts on a tissue cross-section, enabling direct visualization of transcripts locations at high spatial resolution [71]. ..

Fluorescence In Situ Hybridization:

Article Title: Single-Cell Omics in Legumes: Research Trends and Applications.
Article Snippet: .. Spatial transcriptomics can be categorized into (1) RNA capture-based approaches (e.g., 10× Visium, Slide-seq) where tissue sections are placed on slides patterned with spatially barcoded primers that capture RNA molecules and tag them to record their spatial locations; (2) in probe- or imaging-based approaches [e.g., multiplexed error-robust fluorescence in situ hybridization (MERFISH), sequential FISH (seqFISH), Xenium in situ], where fluorescently labeled probes hybridize target transcripts on a tissue cross-section, enabling direct visualization of transcripts locations at high spatial resolution [71]. ..

In Situ:

Article Title: Single-Cell Omics in Legumes: Research Trends and Applications.
Article Snippet: .. Spatial transcriptomics can be categorized into (1) RNA capture-based approaches (e.g., 10× Visium, Slide-seq) where tissue sections are placed on slides patterned with spatially barcoded primers that capture RNA molecules and tag them to record their spatial locations; (2) in probe- or imaging-based approaches [e.g., multiplexed error-robust fluorescence in situ hybridization (MERFISH), sequential FISH (seqFISH), Xenium in situ], where fluorescently labeled probes hybridize target transcripts on a tissue cross-section, enabling direct visualization of transcripts locations at high spatial resolution [71]. ..

Labeling:

Article Title: Single-Cell Omics in Legumes: Research Trends and Applications.
Article Snippet: .. Spatial transcriptomics can be categorized into (1) RNA capture-based approaches (e.g., 10× Visium, Slide-seq) where tissue sections are placed on slides patterned with spatially barcoded primers that capture RNA molecules and tag them to record their spatial locations; (2) in probe- or imaging-based approaches [e.g., multiplexed error-robust fluorescence in situ hybridization (MERFISH), sequential FISH (seqFISH), Xenium in situ], where fluorescently labeled probes hybridize target transcripts on a tissue cross-section, enabling direct visualization of transcripts locations at high spatial resolution [71]. ..

Formalin-fixed Paraffin-Embedded:

Article Title: Netrin-1 blockade inhibits tumour growth and EMT features in endometrial cancer.
Article Snippet: .. Spatial transcriptomics using Visium FFPE technology FFPE tissue sections were placed on Visium slides and prepared according to the 10x Genomics protocols. .. After H&E staining, imaging and de-crosslinking steps, tissue sections were incubated with human-specific probes targeting 17,943 genes (10x Genomics, Visium Human Transcriptome Probe Set v.1.0).



Similar Products

86
Spatial Transcriptomics Inc 10x visium spatial transcriptomics data
(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and <t>Visium</t> spatial <t>transcriptomics</t> for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.
10x Visium Spatial Transcriptomics Data, supplied by Spatial Transcriptomics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/10x+visium/bio_rxiv__2025__10__08__681087-419-7-9
Average 86 stars, based on 1 article reviews
10x visium spatial transcriptomics data - by Bioz Stars, 2026-11
86/100 stars
  Buy from Supplier

90
10X Genomics 10x visium spatial transcriptome hd data
(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and <t>Visium</t> spatial <t>transcriptomics</t> for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.
10x Visium Spatial Transcriptome Hd Data, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/spatial+transcriptome+visium/pm40222008-410-1-13
Average 90 stars, based on 1 article reviews
10x visium spatial transcriptome hd data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics 10x visium mouse anterior brain spatial transcriptomics data
(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and <t>Visium</t> spatial <t>transcriptomics</t> for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.
10x Visium Mouse Anterior Brain Spatial Transcriptomics Data, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/10x+genomics+chromium+platform/pm39815104-288-52-60
Average 90 stars, based on 1 article reviews
10x visium mouse anterior brain spatial transcriptomics data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics 10x visium human breast cancer spatial transcriptomics data
(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and <t>Visium</t> spatial <t>transcriptomics</t> for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.
10x Visium Human Breast Cancer Spatial Transcriptomics Data, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/10x+genomics+chromium+platform/pm39815104-288-63-60
Average 90 stars, based on 1 article reviews
10x visium human breast cancer spatial transcriptomics data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics 10x visium mouse coronal brain spatial transcriptomics data
(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and <t>Visium</t> spatial <t>transcriptomics</t> for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.
10x Visium Mouse Coronal Brain Spatial Transcriptomics Data, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/10x+genomics+chromium+platform/pm39815104-288-98-106
Average 90 stars, based on 1 article reviews
10x visium mouse coronal brain spatial transcriptomics data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics 10x visium zebrafish melanoma spatial transcriptomics data
(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and <t>Visium</t> spatial <t>transcriptomics</t> for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.
10x Visium Zebrafish Melanoma Spatial Transcriptomics Data, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/10x+visium+zebrafish+melanoma+spatial+transcriptomics+data/pm39815104-288-73-95
Average 90 stars, based on 1 article reviews
10x visium zebrafish melanoma spatial transcriptomics data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics 10x visium mouse olfactory bulb spatial transcriptomics data
(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and <t>Visium</t> spatial <t>transcriptomics</t> for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.
10x Visium Mouse Olfactory Bulb Spatial Transcriptomics Data, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/10x+genomics+chromium+platform/pm39815104-288-87-95
Average 90 stars, based on 1 article reviews
10x visium mouse olfactory bulb spatial transcriptomics data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics 10x visium spatial transcriptomics data from human colorectal cancer
(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and <t>Visium</t> spatial <t>transcriptomics</t> for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.
10x Visium Spatial Transcriptomics Data From Human Colorectal Cancer, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/10x+visium+spatial+transcriptomics+data+from+human+colorectal+cancer/bio_rxiv__2025__01__03__631121-175-8-14
Average 90 stars, based on 1 article reviews
10x visium spatial transcriptomics data from human colorectal cancer - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
10X Genomics 10x genomics visium spatial transcriptomic data
(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and <t>Visium</t> spatial <t>transcriptomics</t> for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.
10x Genomics Visium Spatial Transcriptomic Data, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/10x+visium+spatial+transcriptomics+data/spatial+transcriptome+visium/pm39722404-57-3-1
Average 90 stars, based on 1 article reviews
10x genomics visium spatial transcriptomic data - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


(a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and Visium spatial transcriptomics for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.

Journal: bioRxiv

Article Title: Histology and spatial transcriptomic integration revealed infiltration zone with specific cell composition as a prognostic hotspot in glioblastoma

doi: 10.1101/2025.10.08.681087

Figure Lengend Snippet: (a) Overview of the clustering approach and characterization of identified regions. i) Features are extracted from each tiles of H&E slides using the histology foundation model H-optimus-0. ii) Tile features from each slide are clustered using K-means, trained on the discovery cohort (cohort A) and applied to the validation cohorts (cohorts B and C). iii) Expert neuropathologists review and annotate each cluster to define distinct regions. (b) Methods overview. Left : Graphical representation of the methods used to align paired H&E and Visium spatial transcriptomics for cell type annotation in 31 samples from Cohort B from the MOSAIC consortium. Right: Overview of the method used to categorize tiles according to their tile score and tile prediction in 3 classes: high score + high prediction = Long Survival, high score + low prediction = Short Survival, all others = Non-informative. (c) Schematic representation of common spatial arrangements of the regions within tumor sections. (d) Proportion of tiles associated with short survival, long survival, and non-informative categories in the validation cohort in the different regions (excluding the 4 regions with necrosis, hemorrhage, and artefacts) (cohorts B and C). (e) Distribution of regions among Long Survival and Short Survival tiles in the validation cohorts (cohorts B and C). (f) Average of cell count per cell type in the different tissue regions as estimated using the output weights of the cell2loc deconvolution algorithm and 31 samples from cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq. Rare cell types (median counts < 0.1) were excluded.

Article Snippet: Differential expression analysis (DEA) was performed on 10x Visium spatial transcriptomics data using a 2-step approach.

Techniques: Biomarker Discovery, Cell Counting

(a) Distributions of the number of nuclei per tile and the median nuclear area per tile across 457 samples in cohort A (training dataset). Only tiles with a tile score > 0 were included. Purple lines denote thresholds optimized on the training set; arrows indicate the direction associated with shorter survival. *** indicates p value < 0.001 for a Mann Whitney U test between two boxplots. (b) Proportion of biomarker-positive tiles defined as infiltrated white matter (liWM) regions with >30 nuclei and a median nuclear area <40 µm² among all tumor tiles in short- and long-surviving patients from cohorts B and C (testing dataset). (c) Representative H&E slide and corresponding Visium spatial transcriptomics overlay (validation dataset) showing biomarker positive liWM tiles (dark purple) in comparison to adjacent liWM tissue (purple). (d) Cell type composition per tile in biomarker-positive liWM tiles versus non informative liWM tiles in the n=31 patients of the MOSAIC dataset. Cell types with median count per tile <0.1 were excluded for clarity. (e) Pathways enriched in short survival liWM vs non informative liWM. Raster plot of GSEA showing leading genes of each pathways by log2FoldChange. Only pathways with FDR<0.2 were included (See GSEA results and all genes in Supplementary table I and Table J [Supplementary material]). (f) Volcano plot for DEA of short survival liWM vs non informative liWM.

Journal: bioRxiv

Article Title: Histology and spatial transcriptomic integration revealed infiltration zone with specific cell composition as a prognostic hotspot in glioblastoma

doi: 10.1101/2025.10.08.681087

Figure Lengend Snippet: (a) Distributions of the number of nuclei per tile and the median nuclear area per tile across 457 samples in cohort A (training dataset). Only tiles with a tile score > 0 were included. Purple lines denote thresholds optimized on the training set; arrows indicate the direction associated with shorter survival. *** indicates p value < 0.001 for a Mann Whitney U test between two boxplots. (b) Proportion of biomarker-positive tiles defined as infiltrated white matter (liWM) regions with >30 nuclei and a median nuclear area <40 µm² among all tumor tiles in short- and long-surviving patients from cohorts B and C (testing dataset). (c) Representative H&E slide and corresponding Visium spatial transcriptomics overlay (validation dataset) showing biomarker positive liWM tiles (dark purple) in comparison to adjacent liWM tissue (purple). (d) Cell type composition per tile in biomarker-positive liWM tiles versus non informative liWM tiles in the n=31 patients of the MOSAIC dataset. Cell types with median count per tile <0.1 were excluded for clarity. (e) Pathways enriched in short survival liWM vs non informative liWM. Raster plot of GSEA showing leading genes of each pathways by log2FoldChange. Only pathways with FDR<0.2 were included (See GSEA results and all genes in Supplementary table I and Table J [Supplementary material]). (f) Volcano plot for DEA of short survival liWM vs non informative liWM.

Article Snippet: Differential expression analysis (DEA) was performed on 10x Visium spatial transcriptomics data using a 2-step approach.

Techniques: MANN-WHITNEY, Biomarker Discovery, Comparison

(a). In cohort A, proportion of tiles associated with short survival, long survival, and non-informative categories in pooled tissue subtypes Tumor 1.0, Tumor 1.1, and Tumor 2.1. (b). Within pooled tissue subtypes Tumor 1.0, Tumor 1.1, and Tumor 2.1, distributions of nuclear morphology features like nuclear density (number of nuclei per tile) and nuclear size (median nuclear area in µm²) and median nuclear circularity. (c) Representative images of the annotated vessels subtypes patterns on H&E slides (20X): (i) thin endothelium capillary (TEC), (ii) hyperplasic endothelium capillary (HEC), (iii) Microvascular Proliferation (MVP) (iv) Thin Endothelium Wide Lumen (TEWL) (v) Hyperplasic Endothelium Wide Lumen (HEWL) (d) Relative ratios of tiles with vessels or specific vessels subtypes within tumor regions (1.0, 1.1 and 2.1) for each patients across the two survival group (2y < OS and OS > 3y). Distributions are computed for the training set (cohort A) and validation set (cohort B&C). Vessels presence and vessels subtypes detection are obtained after inference by the vessels detection and vessels subtypes classifier models on the entire cohorts. (e) Distribution of cell count per cell type in the tumor regions (1.0, 1.1 and 2.1) for short-survival, long-survival and non-informative tiles. Distributions of cell counts statistically significantly different (Mann–Whitney test; threshold at 0.05) are indicated with a star. 31 samples from Cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq were used. Cell types with low range of mean count variations across tissue regions were removed for clarity. (f) Illustration of the pathway enrichment analyses of the differential expressed genes between long- and short-survival. Negative fold change is associated with worse survival outcomes and positive with better survival outcomes. (See GSEA results and all genes in supplementary table L [Supplementary material])

Journal: bioRxiv

Article Title: Histology and spatial transcriptomic integration revealed infiltration zone with specific cell composition as a prognostic hotspot in glioblastoma

doi: 10.1101/2025.10.08.681087

Figure Lengend Snippet: (a). In cohort A, proportion of tiles associated with short survival, long survival, and non-informative categories in pooled tissue subtypes Tumor 1.0, Tumor 1.1, and Tumor 2.1. (b). Within pooled tissue subtypes Tumor 1.0, Tumor 1.1, and Tumor 2.1, distributions of nuclear morphology features like nuclear density (number of nuclei per tile) and nuclear size (median nuclear area in µm²) and median nuclear circularity. (c) Representative images of the annotated vessels subtypes patterns on H&E slides (20X): (i) thin endothelium capillary (TEC), (ii) hyperplasic endothelium capillary (HEC), (iii) Microvascular Proliferation (MVP) (iv) Thin Endothelium Wide Lumen (TEWL) (v) Hyperplasic Endothelium Wide Lumen (HEWL) (d) Relative ratios of tiles with vessels or specific vessels subtypes within tumor regions (1.0, 1.1 and 2.1) for each patients across the two survival group (2y < OS and OS > 3y). Distributions are computed for the training set (cohort A) and validation set (cohort B&C). Vessels presence and vessels subtypes detection are obtained after inference by the vessels detection and vessels subtypes classifier models on the entire cohorts. (e) Distribution of cell count per cell type in the tumor regions (1.0, 1.1 and 2.1) for short-survival, long-survival and non-informative tiles. Distributions of cell counts statistically significantly different (Mann–Whitney test; threshold at 0.05) are indicated with a star. 31 samples from Cohort B with paired H&E, Visium spatial transcriptomics, and scRNAseq were used. Cell types with low range of mean count variations across tissue regions were removed for clarity. (f) Illustration of the pathway enrichment analyses of the differential expressed genes between long- and short-survival. Negative fold change is associated with worse survival outcomes and positive with better survival outcomes. (See GSEA results and all genes in supplementary table L [Supplementary material])

Article Snippet: Differential expression analysis (DEA) was performed on 10x Visium spatial transcriptomics data using a 2-step approach.

Techniques: Biomarker Discovery, Cell Counting, MANN-WHITNEY